Canada markets closed

Kiniksa Pharmaceuticals, Ltd. (KNSA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.08+0.70 (+3.61%)
At close: 04:00PM EDT
20.08 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.42B
Enterprise Value 1.22B
Trailing P/E 154.46
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.80
Price/Book (mrq)3.30
Enterprise Value/Revenue 4.05
Enterprise Value/EBITDA -43.17

Trading Information

Stock Price History

Beta (5Y Monthly) 0.30
52-Week Change 347.49%
S&P500 52-Week Change 322.38%
52 Week High 322.09
52 Week Low 312.94
50-Day Moving Average 319.16
200-Day Moving Average 317.81

Share Statistics

Avg Vol (3 month) 3387.67k
Avg Vol (10 day) 3466.36k
Shares Outstanding 540.31M
Implied Shares Outstanding 670.94M
Float 830.03M
% Held by Insiders 13.93%
% Held by Institutions 189.75%
Shares Short (Apr 15, 2024) 43.64M
Short Ratio (Apr 15, 2024) 49.94
Short % of Float (Apr 15, 2024) 411.74%
Short % of Shares Outstanding (Apr 15, 2024) 45.14%
Shares Short (prior month Mar 15, 2024) 42.87M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 2.87%
Operating Margin (ttm)-20.71%

Management Effectiveness

Return on Assets (ttm)-3.97%
Return on Equity (ttm)2.11%

Income Statement

Revenue (ttm)301.77M
Revenue Per Share (ttm)4.29
Quarterly Revenue Growth (yoy)65.20%
Gross Profit (ttm)N/A
EBITDA -28.33M
Net Income Avi to Common (ttm)8.65M
Diluted EPS (ttm)0.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)213.55M
Total Cash Per Share (mrq)3.01
Total Debt (mrq)12.14M
Total Debt/Equity (mrq)2.81%
Current Ratio (mrq)4.21
Book Value Per Share (mrq)6.10

Cash Flow Statement

Operating Cash Flow (ttm)21.55M
Levered Free Cash Flow (ttm)26.97M